Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodixanol vs Iohexol in CI-AKI Prevention During Primary PCI for AMI
ChiCTR-IPR-16010141Phase 4Recruiting
- Sponsor
- General Hospital of Southern Theater Command of the People's Liberation Army
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in contrast-induced nephropathy (CIN) comparing Iodixanol with Iohexol (2 arms). Primary endpoint: Incidence of contrast-induced acute kidney injury (CI-AKI). Started Jul 2015; status: recruiting.
02
Drugs
iodixanoliohexol
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on ChiCTR-IPR-16010141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16010141.